Ocrelizumab - a monoclonal antibody - in the treatment of adult patients with multiple sclerosis: a systematic review

• Main Authors: D. L. Klabukova (Author), M. E. Holownia-Voloskova (Author), M. V. Davydovskaya (Author), T. N. Ermolaeva (Author), K. I. Polyakova (Author), A. G. Fisun (Author), K. A. Kokushkin (Author)
• Format: Book
• Published: IRBIS LLC, 2018-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: To analyze the efficacy, safety and pharmacoeconomic aspects of using ocrelizumab in adult patients with relapsing/remitting multiple sclerosis (R/R MS).Materials and Methods. We used the commonly accepted PICo(S) questionnaire with the following specifics: the population - patients with R/R MS...